Non-Malignant Diseases Requiring Stem Cell Transplantation

[1]  F. Cachat,et al.  Perioperative care of children with sickle cell disease: A systematic review and clinical recommendations , 2020, American journal of hematology.

[2]  E. Ernst,et al.  Successful pregnancy in a woman previously suffering from β-thalassemia following transplantation of ovarian tissue cryopreserved before puberty. , 2018, Minerva ginecologica.

[3]  E. Vichinsky,et al.  Fertility and Pregnancy in Women with Transfusion-Dependent Thalassemia. , 2018, Hematology/oncology clinics of North America.

[4]  M. Matthews,et al.  Acute pain crisis in a patient with sickle cell disease undergoing ovarian simulation for fertility preservation prior to curative stem cell transplantation: case report and literature review , 2017, Journal of Assisted Reproduction and Genetics.

[5]  G. Lucchini,et al.  Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT and the International BFM Study Group , 2017, Bone Marrow Transplantation.

[6]  G. Lucchini,et al.  State-of-the-art fertility preservation in children and adolescents undergoing haematopoietic stem cell transplantation: a report on the expert meeting of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) in Baden, Austria, 29–30 Septemb , 2017, Bone Marrow Transplantation.

[7]  A. Gennery,et al.  Impact of drug development on the use of stem cell transplantation: a report by the European Society for Blood and Marrow Transplantation (EBMT) , 2017, Bone Marrow Transplantation.

[8]  Kayla L. Stratton,et al.  Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort. , 2016, The Lancet. Oncology.

[9]  E. Lanino,et al.  Two pregnancies shortly after transplantation with reduced intensity conditioning in chronic myeloid leukemia , 2016, Pediatric transplantation.

[10]  R. Ware,et al.  Hydroxyurea therapy for sickle cell anemia , 2015, Expert opinion on drug safety.

[11]  S. Nussey,et al.  Gonadal function and fertility after stem cell transplantation in childhood: comparison of a reduced intensity conditioning regimen containing melphalan with a myeloablative regimen containing busulfan , 2015, British journal of haematology.

[12]  A. Mertens,et al.  The effects of hydroxyurea and bone marrow transplant on Anti-Müllerian hormone (AMH) levels in females with sickle cell anemia. , 2015, Blood cells, molecules & diseases.

[13]  K. Smith-Whitley.  Reproductive issues in sickle cell disease. , 2014, Blood.

[14]  William J Savage,et al.  Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. , 2014, JAMA.

[15]  A. Gennery,et al.  Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation , 2014, Bone Marrow Transplantation.

[16]  K. Jahnukainen,et al.  Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence. , 2014, European journal of endocrinology.

[17]  U. Dirksen,et al.  Dynamics of fertility impairment and recovery after allogeneic haematopoietic stem cell transplantation in childhood and adolescence: results from a longitudinal study , 2014, Journal of Cancer Research and Clinical Oncology.

[18]  M. Gamerre,et al.  Impact of reduced-intensity conditioning allogeneic stem cell transplantation on women's fertility. , 2013, Clinical lymphoma, myeloma & leukemia.

[19]  T. Keil,et al.  Childhood leukemia and its impact on graduation and having children: results from a national survey , 2012, Leukemia & lymphoma.

[20]  T. Keil,et al.  Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence , 2012, Bone Marrow Transplantation.

[21]  C. Gracia,et al.  Oocyte cryopreservation in a patient with sickle cell disease prior to hematopoietic stem cell transplantation: first report , 2012, Journal of Assisted Reproduction and Genetics.

[22]  C. Gracia,et al.  NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  Scott T. Miller,et al.  Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) , 2011, The Lancet.

[24]  E. Vichinsky,et al.  Increased prevalence of iron‐overload associated endocrinopathy in thalassaemia versus sickle‐cell disease , 2006, British journal of haematology.

[25]  A. Jarisch,et al.  Haemopoietic stem cell transplantation for genetic disorders , 2005, Archives of Disease in Childhood.

[26]  M. Angastiniotis,et al.  The impact of iron overload and genotype on gonadal function in women with thalassaemia major. , 2004, Pediatric endocrinology reviews : PER.

[27]  W. Levy,et al.  Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. , 1996, Blood.